Monopar Therapeutics Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 8 - Commitments and Contingencies (Tables)

Note 8 - Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2026

Notes Tables

Lease, Cost [Table Text Block]

		*Three Months Ended March 31,*
		*2026*				*2025*
Total lease costs		$	27,497			$	14,312

		March 31,
		2026				2025
Lease term:
Operating leases (in years)			1.78				0.83

Discount rate:
Operating lease			6.50	%			6.50	%

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

Fiscal Year Ending December 31,		Operating Leases
2026		$	85,118
2027			102,984
2028			60,760
Total lease payments		$	248,862
Less: imputed interest			(18,437	)
Total lease liability as of March 31, 2026		$	230,425

Supplemental Balance Sheet Lease Information [Table Text Block]

		As of March 31,
		2026				2025
ROU asset - non-current		$	239,882			$	9,102
Total ROU asset		$	239,882			$	9,102

Operating lease liability - current		$	98,860			$	8,252
Operating lease liability - non-current			131,565				—
Total operating lease liabilities		$	230,425			$	8,252